Contents

Current Molecular Imaging (Discontinued), Volume 2 - Number 2

Molecular Markers of Glioblastoma and the Potential for Integration with Imaging: the Future for Assigning Prognosis and Best Treatment Strategy

, 2(2): 107 - 116

Noelyn A. Hung, Janice A. Royds and Tania L. Slatter


DOI: 10.2174/2211555211302020001




Evaluation of Tophaceous Gout by FDG-PET/CT and Bone Scan

, 2(2): 117 - 119

Gottfried Wimmer, Simon W. Stoecklegger, Tatjana Stojakovic, Josef F. Hofer and Robert Pichler


DOI: 10.2174/2211555211302020002




Application of Radiolabeled Antibodies in Targeting Therapy of Breast Cancer

, 2(2): 120 - 129

Zahra Heidari, Mojtaba Salouti and Reyhaneh Sariri


DOI: 10.2174/2211555211302020003




The Neurotachykinin NK1 Receptor – A Novel Target for Diagnostics and Therapy

, 2(2): 130 - 147

Susanne Nikolaus, Maria Angelica de Souza Silva, Hubertus Hautzel and Hans-Wilhelm Muller


DOI: 10.2174/2211555211302020004




Fabrication of Split-Luciferase Complementation Assays for Molecular Imaging

, 2(2): 148 - 157

Sung Bae Kim and Takeaki Ozawa


DOI: 10.2174/22115552113029990001




Local Recurrence vs Radiotherapy-Induced Edema in Advanced Laryngeal Carcinoma: Is FDG PET/CT Up to the Challenge?

, 2(2): 158 - 163

Sagi Tshori, Martine Klein, Jeffrey Weinberger, Roland Chisin and Nanette Freedman


DOI: 10.2174/22115552113029990010




In Vivo Monitoring of Cell Based Therapy in the Liver

, 2(2): 164 - 176

Ashwini Ketkar-Atre and Uwe Himmelreich


DOI: 10.2174/22115552113029990011




Biological Applications of ZnO Nanoparticles

, 2(2): 177 - 192

Hua-Juan Zhang and Huan-Ming Xiong


DOI: 10.2174/22115552113029990012




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science